LEMAITRE VASCULAR, INC. Operating Lease, Liability, Current
LEMAITRE VASCULAR, INC. (LMAT) had Operating Lease, Liability, Current of $3.44 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability, Current $3.44M.
- 2026-03-31: Operating Lease, Liability, Current $3.45M.
- 2025-12-31: Operating Lease, Liability, Current $2.94M.
- 2025-09-30: Operating Lease, Liability, Current $2.79M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $3.44M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $3.45M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $2.94M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $2.79M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.83M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $2.63M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.68M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.72M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.59M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.53M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $2.47M 10-K · filed 2025-02-28 |
| 2023-09-30 | $2.75M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.36M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.06M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.89M 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.83M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.79M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $1.87M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.87M 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.90M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.95M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.85M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.95M 10-K · filed 2022-02-28 |
| 2020-09-30 | $1.81M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.77M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.70M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.76M 10-K · filed 2021-03-12 |
| 2019-09-30 | $1.67M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.70M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.44M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |